Bluebird Bio and Resilience Announce Strategic Alliance to Develop Next Generation Cell Therapies

SAN DIEGO & BOSTON & CAMBRIDGE, Mass.–(BUSINESS WIRE)–National Resilience, Inc. (Resilience) and bluebird bio, Inc. (NASDAQ: BLUE), today announced a strategic alliance aimed to accelerate the early research, development and delivery of cell therapies. As part of the agreement, Resilience will acquire bluebird’s Research Triangle (bRT) manufacturing facility located in North Carolina and retain all of the more than 100 highly skilled technical staff and administrators currently employed at th
Click here to view original post